Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734667 · ClinicalTrials.gov registry record · NA
Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes
A NA study of Type 1 Diabetes Mellitus, sponsored by Korey Hood.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT02734667 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Korey Hood. The registered enrollment target is 120 participants, below the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02734667, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Korey Hood.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.
Conditions Studied
Interventions
- DEVICE CGM at diagnosis of T1D
Study Locations (2)
California
- Stanford University - Stanford
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734667
The ClinicalTrials.gov registry entry for NCT02734667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (14% lower). The listed sponsor is Korey Hood, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which CGM at diagnosis of T1D is the first listed.
NCT02734667 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Colorado.
Frequently Asked Questions
What is clinical trial NCT02734667 about?
NCT02734667 is a clinical study titled "Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes". The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.
What is the current status of trial NCT02734667?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2016-02. Estimated completion is 2020-02.
What conditions does trial NCT02734667 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT02734667?
The interventions under investigation include: CGM at diagnosis of T1D (DEVICE).
Who is sponsoring clinical trial NCT02734667?
This trial is sponsored by Korey Hood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02734667 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.